BayBridge Capital Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.66M Buy
+1,434
New +$1.69M 0.87% 35
2025
Q1
– Sell
-684
Closed -$528K – 105
2024
Q4
$528K Buy
684
+2
+0.3% +$1.66K 0.38% 64
2024
Q3
$604K Sell
682
-40
-6% -$36K 0.44% 56
2024
Q2
$653K Buy
722
+19
+3% +$15.2K 0.51% 49
2024
Q1
$514K Sell
703
-82
-10% -$58.4K 0.45% 51
2023
Q4
$504K Buy
+785
New +$458K 0.47% 50

Other funds holding LLY

BayBridge Capital Group's LLY Position: Q3 2026 in Review

BayBridge Capital Group opened a new position in Eli Lilly (LLY) in Q3 2026: 1,434 shares worth $1.66M. The stake represents 0.87% of the portfolio and ranks #35 among its holdings. This is a return to the name: BayBridge Capital Group previously reported a position in LLY as recently as Q4 2024.

BayBridge Capital Group first reported a position in LLY in Q4 2023 and has held it in 6 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • BayBridge Capital Group held 1,434 shares of Eli Lilly worth $1.66M as of Q3 2026.
  • Eli Lilly was a new BayBridge Capital Group position in Q3 2026.
  • Eli Lilly made up 0.87% of BayBridge Capital Group's portfolio in Q3 2026, its #35 holding.
  • BayBridge Capital Group first reported a position in Eli Lilly in Q4 2023 and has held it in 6 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on BayBridge Capital Group's 13F filing for Q3 2026, filed 13 Oct 2026.